Answers are grounded in this paper and cite their sources.
Spatially organized tumor-stromal interactions contribute to metabolic remodeling and immune suppression in bladder cancer (BLCA). Using spatial transcriptional programs to define single-cell states, we identified a niche comprising SPINK1-high epithelial cells (E2) and TPM2-high cancer-associated fibroblasts (CAFs) (C1). SPINK1 promoted tumor growth and myofibroblastic CAF programs, with EGFR and TGF-β signaling implicated in tumor-CAF communication. Inferred metabolic reactions and spatial metabolite distributions supported a candidate circuit linking tumor-derived lactate to CAF oxidative metabolism and glutamine provision, followed by tumor glutamine utilization for reductive carboxylation and fatty acid synthesis. SPINK1 perturbation altered extracellular glutamine and lactate concentrations. Predicted chemokine interactions implicated C2/C3 CAFs in T cell recruitment, whereas the E2-C1 niche exhibited checkpoint and exhaustion-associated features. RHCG-positive tumor regions contained higher proportions of TOX⁺CXCR4⁺ cells among CD3⁺ T cells, suggesting a possible association between ammonia handling and T cell dysfunction. In vivo, Spink1 loss attenuated tumor progression, increased cytotoxic CD8⁺ T-cell infiltration, and enhanced tumor control during PD-1 blockade. These findings identify a spatially organized tumor-stromal niche associated with metabolic cooperation and immune restriction, supporting SPINK1 as a candidate therapeutic target in combination with immunotherapy.
No takes yet. Share an insight, caveat, or question.
Yu et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: